HAYWARD, Calif.--(BUSINESS WIRE)--May 16, 2024--

Related Keywords

Boston , Massachusetts , United States , Pavel Hala , Keita Watanabe , Jacobs Koruth , Jan Petru , Mohit Turagam , Anita Crompton , Joshua Lampert , David Danitz , Moritoshi Funasako , William Whang , Gansevoort Hurlbut Dunnington , Daniel Musikantow , Ilya Getsin , Abhishek Mann , Roman Turovskiy , Jan Skoda , Darrin Uecker , Marca Miller , Petr Neuzil , Mike Smith , Srinivasr Dukkipati , Lauren Johnston , Viveky Reddy , Jeffrey Litt , Burket Barrett , Pulse Biosciences Inc , Heart Rhythm Society , Nasdaq , Boston Convention Exhibition Center , Exchange Commission , Company Cell , Nanosecond Pulsed Field Ablation , Chief Technology Officer , Chief Executive Officer Burke , Pulse Biosciences , Exhibition Center , Case Site , Case Operators , Understanding Novel Ablation Technologies , Poster Hub , Pulsed Field Myocardial Ablation , Preclinical Evaluation , Novel Catheter , Moritz Nies , Human Clinical Experience , Pulse Field Ablation Using Nanosecond Pulses , Treat Atrial Fibrillation , Poster Session , Preclinical Assessment , Novel Catheter Tip Design , Esophageal Effects After Pulsed Field Ablation , Nanosecond Pulse , Dedicated Endocardial System , First Bipolar Nanosecond Pulsed Field Ablation , Chronic Porcine Model , Hurlbut Dunnington , Swami Gnanashanmugam , Consistent Endocardial , Epicardial Transmural Ablation Lesions Using , New Nanosecond Pulsed Field Ablation , Chad Brodt , Nano Pulse Stimulation , Pulse Bioscience , Investor Contacts , Business Wire ,